Cardiovascular Systems Inc (CSII) Holdings Reduced by Frontier Capital Management Co. LLC

Frontier Capital Management Co. LLC decreased its holdings in Cardiovascular Systems Inc (NASDAQ:CSII) by 2.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 791,119 shares of the medical device company’s stock after selling 17,525 shares during the quarter. Frontier Capital Management Co. LLC owned approximately 2.32% of Cardiovascular Systems worth $18,742,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. BNP Paribas Arbitrage SA lifted its stake in shares of Cardiovascular Systems by 160.7% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 5,135 shares of the medical device company’s stock valued at $166,000 after purchasing an additional 3,165 shares in the last quarter. BlueCrest Capital Management Ltd acquired a new position in shares of Cardiovascular Systems in the 2nd quarter valued at about $204,000. Legal & General Group Plc lifted its stake in shares of Cardiovascular Systems by 2.9% in the 2nd quarter. Legal & General Group Plc now owns 7,763 shares of the medical device company’s stock valued at $249,000 after purchasing an additional 216 shares in the last quarter. Advisor Group Inc. lifted its stake in shares of Cardiovascular Systems by 0.4% in the 2nd quarter. Advisor Group Inc. now owns 8,165 shares of the medical device company’s stock valued at $263,000 after purchasing an additional 35 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in shares of Cardiovascular Systems by 34.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 8,239 shares of the medical device company’s stock valued at $265,000 after purchasing an additional 2,115 shares in the last quarter. Institutional investors own 75.31% of the company’s stock.

CSII has been the topic of several research analyst reports. Needham & Company LLC lowered Cardiovascular Systems from a “buy” rating to a “hold” rating and reduced their price objective for the company from $33.11 to $23.00 in a research note on Friday, December 15th. William Blair reaffirmed a “market perform” rating on shares of Cardiovascular Systems in a research note on Thursday, December 21st. Raymond James Financial reaffirmed a “hold” rating on shares of Cardiovascular Systems in a research note on Monday, December 4th. Zacks Investment Research raised Cardiovascular Systems from a “sell” rating to a “hold” rating in a research note on Monday, November 13th. Finally, BidaskClub raised Cardiovascular Systems from a “strong sell” rating to a “sell” rating in a research note on Thursday. Two analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $31.50.

Cardiovascular Systems Inc (CSII) opened at $25.98 on Monday. The firm has a market capitalization of $886.48, a PE ratio of -432.93 and a beta of 2.53. Cardiovascular Systems Inc has a 52 week low of $23.00 and a 52 week high of $33.11. The company has a quick ratio of 3.83, a current ratio of 4.30 and a debt-to-equity ratio of 0.18.

Cardiovascular Systems (NASDAQ:CSII) last released its quarterly earnings results on Wednesday, October 25th. The medical device company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.02. The firm had revenue of $49.70 million for the quarter, compared to analyst estimates of $51.00 million. Cardiovascular Systems had a positive return on equity of 0.74% and a negative net margin of 0.93%. Cardiovascular Systems’s revenue for the quarter was down .2% on a year-over-year basis. During the same period in the previous year, the company posted ($0.06) EPS. sell-side analysts anticipate that Cardiovascular Systems Inc will post -0.03 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Cardiovascular Systems Inc (CSII) Holdings Reduced by Frontier Capital Management Co. LLC” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be read at https://www.dispatchtribunal.com/2018/01/22/cardiovascular-systems-inc-csii-holdings-reduced-by-frontier-capital-management-co-llc.html.

About Cardiovascular Systems

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems Inc (NASDAQ:CSII).

Institutional Ownership by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply